Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, MS
Diabetologist
M.B.B.S., M.C.P.S, Ph.D
Gastroenterologist
M.B.B.S., M.C.P.S, F.C.P.S., M.R.C.P
Rheumatologist
M.B.B.S., F.C.P.S. (General Medicine), F.C.P.S. (Rheumatology)
Internal Medicine Specialist
M.B.B.S., M.D.
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine), CEFM
Internal Medicine Specialist
M.D, M.R.C.P. (UK), FACP (USA), Critical Care Nephrology Fellowship
Internal Medicine Specialist
M.D, M.R.C.P. (UK), FACP (USA), Critical Care Nephrology Fellowship
Consultant Physician
MBBS, FCPS (Medicine), MRCP-UK
Internal Medicine Specialist
MBBS, FACP (USA), FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures